This study evaluated whether the presence of a trans-anastomotic stent affects the predictive value of drain fluid amylase (DFA) for postoperative pancreatic fistula (POPF) following pancreatoduodenectomy (PD).
Trans-anastomotic stenting did not significantly alter the predictive performance of drain fluid amylase for POPF after pancreatoduodenectomy.
The paper abstract provides limited methodological detail; sample size, specific DFA thresholds used, and stent type/placement protocols are not described in the available text.
Clinicians can continue to use drain fluid amylase as a reliable predictor of pancreatic fistula after pancreatoduodenectomy, regardless of whether a trans-anastomotic stent was placed. Stent use does not appear to require recalibration of DFA-based decision thresholds.
Explore related topics
